Search for: "Pharms v. U.s.*"
Results 361 - 380
of 384
Sort by Relevance
|
Sort by Date
11 Dec 2008, 10:30 pm
Zenith Goldline Pharm., 364 F. [read post]
2 Oct 2008, 4:27 am
Rost v. [read post]
5 Sep 2008, 8:28 am
Teva Pharms. [read post]
26 Jul 2008, 4:02 pm
Caraco Pharm. [read post]
4 May 2008, 9:58 pm
FDA, concerning 180-day exclusivity on Risperdal, in which Apotex filed a motion to intervene; Nu-Pharm v. [read post]
24 Apr 2008, 9:57 pm
Medicis Pharm., No. [read post]
21 Apr 2008, 11:44 am
Circuit Court of Appeals, April 18, 2008 Pharm. [read post]
10 Mar 2008, 8:26 am
Pfizer v. [read post]
4 Mar 2008, 3:04 am
In Micron Tech. v. [read post]
3 Mar 2008, 9:27 pm
Ivax Pharm., Inc. [read post]
4 Dec 2007, 5:55 pm
Andrx Pharms., Inc., 473 F.3d 1196, 1201 (Fed. [read post]
20 Nov 2007, 4:05 am
"Slaby v. [read post]
13 Nov 2007, 12:51 pm
Yung Shin Pharms. [read post]
14 Oct 2007, 7:52 pm
Abbott Labs v. [read post]
11 Oct 2007, 9:56 pm
Abbott Labs v. [read post]
10 Oct 2007, 8:29 pm
In Abbott Laboratories v. [read post]
5 Oct 2007, 9:35 am
The first dealt with obviousness.To read the full decision in Somerset Pharms., Inc. v. [read post]
20 Sep 2007, 10:05 pm
Geneva Pharms., Inc., 287 F. [read post]
12 Sep 2007, 4:59 am
Ivax Pharms., Inc., No. 07-1059, slip op. at 10-11 (Fed. [read post]
25 Jul 2007, 3:15 pm
Astra offers no convincing reason why Emert does not apply.2 See also Geneva Pharms., Inc. v. [read post]
